Germany’s Dax traded lower on Monday after German chancellor Angela Merkel secured a fourth term but saw her party weakened by a surge in support for the far-right. Photograph: Krisztian Bocsi/Bloomberg

European shares rose on Monday after the euro weakened following the increase in support for the far-right Alternative für Deutschland (AfD) party in (...)

Boxes of tablets produced by Teva. The Israeli generics giant  has prised Kaare Schultz from  Lundbeck with a $40m   package. Photograph: Chris Ratcliffe/Bloomberg

Teva Pharmaceutical is betting $40 million (€44.4m) that the man credited with the rapid revival of a Danish drugmaker can do it again – and it’s brea(...)

 EpiPen allergy treatment pens  manufactured by Mylan. Photograph:   ReuterS/Jim Bourg

Mylan on Wednesday cut its forecasts for this year and next as eroding prices for generic drugs and challenges getting new products approved in the US(...)

Pfizer last year failed in its attempt o buy Allergan and move its headquarters to the Republic. Photograph: Bloomberg

Since becoming chief executive of Pfizer in 2010, Ian Read has twice tried to reshape the drugmaker through a transformational acquisition. And twice (...)

    Allergan chairman, chief executive and president Brent Saunders in Dublin with An Taoiseach Enda Kenny Wednesday where he confirmed an investment of €42 million in its Irish operations and details of a new €50,000 Innovation Award Programme with Irish colleges around the country. Allergan also announced that it will become the official sponsor of the Dubai Duty Free Irish Open as part of a three-year sponsorship. Photograph: Leon Farrell/Photocall Ireland.

Dublin-headquartered pharma company Allergan is to invest €42 million in its Irish operations this year. The company, which employs approximately 1,7(...)

CBRE Ireland head of research Marie Hunt: “A heightened perception of risk has negatively impacted demand for secondary assets of late.”

Momentum has been slow in the commercial property market over the opening months of 2017 with few large assets launched for sale and not a huge volume(...)

Allergan’s agreed price for Zeltiq Aesthetics’ shares represents a premium of 14.4 per cent on the company’s Friday close.

Botox maker Allergan said it would buy body-contouring product maker Zeltiq Aesthetics for about $2.48 billion (€2.34 billion), adding muscle to its l(...)

Protesting US president Donald Trump’s executive order travel ban curbing immigration in Boston, Massachusetts. Photograph: Brian Snyder/Reuters

Most US corporate bosses have stayed silent on president Donald Trump’s immigration curbs, underscoring the sensitivities around opposing policies tha(...)

Alongside what was happening globally, Ireland wasn’t short of its own significant deals during the year. Illustration: iStock

Possibly the most important merger of 2016 from the perspective of market impact was the one that didn’t happen. The proposed $160 billion (€150 bill(...)

Banana company Fyffes was taken over by Japanese firm Sumitomo for €751 million.

The technology, agri-food and healthcare/pharma sectors remain firmly in the top three in terms of mergers and acquisitions (M&A) activity in Irel(...)